1 May 2023 in Expert Review of Anticancer Therapy
Colorectal cancer (CRC) is a major health issue, being responsible for nearly 10% of all cancer-related deaths. Since CRC is often an asymptomatic or paucisymptomatic disease until it reaches advanced stages, screening is crucial for the diagnosis of preneoplastic lesions or early CRC. The aim of this review is to summarize the literature evidence on currently available CRC screening tools, with their pros and cons, focusing on the level of accuracy reached by each test over time. We also provide an overview of novel technologies and scientific advances that are currently being investigated and that in the future may represent real game-changers in the field of CRC screening. We suggest that best screening modalities are annual or biennial FIT and colonoscopy every 10 years. We believe that the introduction of artificial intelligence (AI)-tools in the CRC screening field could lead to a significant improvement of the screening efficacy in reducing CRC incidence and mortality in the future. More resources should be put into implementing CRC programmes and support research project to further increase accuracy of CRC screening tests and strategies.
14 April 2023 in Endoscopy
Aims This study aimed to assess the efficacy and safety of rectal ESD for superficial lesions ≥ 8 cm. Methods A total of 138 superficial rectal neoplasms treated by ESD from January 2018 to December 2021 were included in the analysis and allocated in two groups: 25 in the “giant” ESD group and 113 in the control group ([Table 1]). Results Demographic features of the patients were not different between the two groups. LST-GM were more often observed in the “giant” ESD group (96% vs 58% in the control group; p<0.001) while sessile polyps represented 18% of lesions of the control group and 0% in the “Giant” ESD group (p: 0.01). En bloc resection was achieved in 96% of cases in both groups. En bloc R0 resection rate was similar between the “giant” ESD group and the control group (84% vs 86%; p: 0.5) and curative resection was higher in the control group (81%) than in “giant” ESD group (68%) without reaching statistical significance (p: 0.2). Submucosal invasion superior to 1000 µm was more frequent in the “giant” ESD” group than in the control group (24% vs 10%; p: 0.05). Dissection time was significantly longer in the “giant” ESD group (251 vs 108 minutes; p <0.0001), however, dissection speed was significantly higher (0.36 vs 0.17 cm2/min; p=0.02).). Post-ESD stenosis was observed in 2 patients from the “giant” ESD group (8% vs 0% of control group, p 0.03). No significant differences were found in delayed bleeding, perforation, local recurrences, and need for additional surgery. Conclusions ESD for superficial rectal tumors ≥ 8 cm is a feasible and effective therapeutic option. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
14 April 2023 in Endoscopy
Aims Endoscopic mucosal resection (EMR) of superficial non-ampullary duodenal epithelial tumor (SNADETs) is often challenging, and to date, there are few studies assessing the clinical outcomes of EMR in the duodenum. The aim of this study was to evaluate the efficacy and safety of EMR for the treatment of SNADETs >10 mm. Methods This is a retrospective observational single-center study reporting data from a cohort of consecutive patients undergoing EMR of SNADETs between January 2017 and December 2021. Results A total of 81 patients with 83 lesions underwent EMR (70 conventional EMR, 13 underwater EMR). Complete EMR was performed in all cases. The mean size was 24 ± 13 mm. The mean procedure time was 45 ± 30 min and the en-bloc resection rate was 47%. Delayed bleeding occurred in 5 (6%) of EMRs. Only one perforation was observed, which was managed surgically. Recurrence rate was 20% with a median follow-up of 13 months and all the recurrences were treated endoscopically. Lesion size (p=0.02), previous endoscopic resection (p=0.05), previous biopsy (p= <0.001) and piecemeal resection (p= 0.004) were associated with local/residual recurrence ([Table 1]). Conclusions Large duodenal adenomas can be effectively managed with EMR in a referral center. However, EMR has a significant recurrence rate, and the risk of adverse events is not negligible. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany